Atlas Trials

Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer

Clinical trial NCT02016274 · UNKNOWN

Trial details

NCT number
NCT02016274
Sponsor
Shen Lin
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Cancer
Start date
2013-12-01
Primary completion
2015-12-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.